CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance cancer immunotherapy by developing a more efficient method for producing genetically modified immune cells, specifically antibody-modified natural killer cells. By combining metabolic engineering with chemical labeling, the project seeks to improve the speed and cost-effectiveness of these…
Our immune system evolved to protect our bodies from different invaders and to fight against infections and diseases.
Immune cells use sophisticated ways to detect and destroy abnormal cells, while sparing our own cells.
Unluckily, cancer cells often develop sneaky tricks enabling them to evade this protecting machinery and to survive and proliferate.
Immunotherapy, an emerging concept of treatment, aims to employ the power of immune system to fight cancer by boosting or reeducation of immune ce…
USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
